Kamada Ltd. Financial Results and Dividend Declaration

Kamada Ltd. reported strong financial results for 2025, with revenues reaching $180.5 million (a 12% increase year-over-year) and Adjusted EBITDA at $42.0 million (a 23% increase year-over-year). Net income was $20.2 million, a 40% increase from the previous year. The company has affirmed its 2026 guidance, expecting revenues between $200-$205 million and Adjusted EBITDA between $50-$53 million, indicating continued double-digit organic profitable growth. Kamada also announced the adoption of an annual cash dividend policy, intending to distribute at least 50% of its annual net income. Consequently, a cash dividend of $0.25 per share, totaling approximately $14.4 million, has been declared and will be payable on April 6, 2026. The company generated $25.5 million in cash from operations in 2025, ending the year with $75.5 million in available cash. Kamada is focused on expanding its commercial portfolio, growing its distribution segment in Israel and the MENA region, increasing plasma collection operations, and pursuing new mergers and acquisitions to accelerate growth.